Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VCELL 1 for male sexual deficiency
NCT05345418Phase 2Recruiting
- Sponsor
- Vinmec Research Institute of Stem Cell and Gene Technology
- Start
- Apr 2022
- Primary completion
- Jun 2025
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in male sexual dysfunction (MSD), Hypogonadism, sponsored by Vinmec Research Institute of Stem Cell and Gene Technology. Started Apr 2022; status: recruiting.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
male sexual dysfunction (MSD)Hypogonadism
Beyond the preview
Go deeper on NCT05345418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05345418.